Bebac user
☆    

Egypt,
2025-02-25 21:30
(25 d 01:02 ago)

Posting: # 24376
Views: 316
 

 Question about Williams Design [Design Issues]

Post reply
Hello Dears,

Is this study design acceptable?

## Williams design ##

Three treatments, three phases and six sequences.

T1.. Metformin 1000 XR, sitagliptin 100mg and Empagliflozin 25mg.
T2.. Sitagliptin 100mg and Empagliflozin 25mg.
R1.. Metformin 1000 XR, sitagliptin 100mg and Empagliflozin 25mg.

Thanks in advance.
 
UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,670 registered users;
18 visitors (0 registered, 18 guests [including 9 identified bots]).
Forum time: 22:32 CET (Europe/Vienna)

Facts are meaningless. You could use facts to prove
anything that’s even remotely true!    Homer Simpson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5